公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2004 | Negative modulation of androgen receptor transcriptional activity by Daxx | Lin D.-Y.; Fang H.-I.; Ma A.-H.; Huang Y.-S.; YEONG-SHIAU PU ; Jenster G.; Kung H.-J.; Shih H.-M. | Molecular and Cellular Biology | 96 | 92 | |
2018 | A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma | Yen C.-J.; Kim T.-Y.; Feng Y.-H.; Chao Y.; Lin D.-Y.; Ryoo B.-Y.; Huang D.C.-L.; Schnell D.; Hocke J.; Loemb? A.-B.; ANN-LII CHENG | Liver Cancer | 19 | 22 | |
1997 | Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers | MING-WHEI YU ; Hsu F.-C.; Sheen I.-S.; Chu C.-M.; Lin D.-Y.; Chen C.-J.; Liaw Y.-F. | American Journal of Epidemiology | 267 | 234 | |
2013 | Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial | ANN-LII CHENG ; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E. | Journal of Clinical Oncology | 619 | 599 |